• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Neurology Devices Market

    ID: MRFR/HC/17922-HCR
    100 Pages
    Rahul Gotadki
    October 2025

    US Neurology Devices Market Research Report By Product Type (neurostimulation, interventional neurology, csf management, neurosurgery devices) and By End User (hospitals & clinics, specialty center) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Neurology Devices Market Infographic
    Purchase Options

    US Neurology Devices Market Summary

    The US Neurology Devices market is projected to grow from 235.94 USD Billion in 2024 to 541.32 USD Billion by 2035.

    Key Market Trends & Highlights

    US Neurology Devices Key Trends and Highlights

    • The US Neurology Devices market is valued at 235.94 USD Billion in 2024.
    • By 2035, the market is expected to reach 541.32 USD Billion, indicating robust growth.
    • The compound annual growth rate (CAGR) for the period from 2025 to 2035 is estimated at 7.84%.
    • Growing adoption of advanced neurology devices due to increasing prevalence of neurological disorders is a major market driver.

    Market Size & Forecast

    2024 Market Size 235.94 (USD Billion)
    2035 Market Size 541.32 (USD Billion)
    CAGR (2025 - 2035) 7.84%

    Major Players

    Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Meta Platforms Inc (US), Tesla Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

    US Neurology Devices Market Trends

    The US Neurology Devices Market is experiencing a notable shift driven by advancements in technology and an increasing prevalence of neurological disorders. One of the key market drivers is the rise in neurodegenerative diseases such as Alzheimer's and Parkinson's. As the population ages, the demand for innovative devices that can help in early diagnosis and effective management of these conditions continues to grow.

    Additionally, increased funding for research and development from both private and public sectors is promoting innovation in neurology devices, contributing to market expansion. Opportunities in the US market include the development of minimally invasive devices and telemedicine solutions. The ongoing adoption of digital health technologies is transforming how healthcare providers approach treatment and monitoring of neurological conditions. This trend creates opportunities for companies to develop products that improve patient outcomes while reducing costs.

    Furthermore, there is a significant push towards integration of artificial intelligence in neurology devices, which can enhance diagnostic accuracy and treatment personalization. Recent trends emphasize the importance of regulatory support in speeding up product approvals. The US Food and Drug Administration has been issuing guidelines to facilitate quicker access to neurology devices for patients, encouraging market players to invest in innovative products. The increasing awareness about mental health and neurological disorders is also driving interest in therapy devices and supportive technologies aimed at improving the quality of life for affected individuals.

    As these trends continue to evolve, the US neurology devices market is poised for dynamic growth, enhancing the future of neurological care.

    Market Segment Insights

    Neurology Devices Market Product Type Insights

    Interventional neurology is another noteworthy area within the US Neurology Devices Market, characterized by its focus on minimally invasive surgical procedures aimed at the treatment of various neurological conditions such as stroke and vascular disorders. This segment benefits from technological advancements, including improved imaging techniques and robotic assistance, allowing for increased precision and improved patient recovery times. The growing prevalence of vascular diseases in the US population further highlights the importance of interventional neurology in addressing critical health challenges.

    Cerebrospinal fluid (CSF) management devices, which are essential for treating conditions that affect the flow of cerebrospinal fluid, also play a significant role in the market. These devices are crucial for patients suffering from conditions such as hydrocephalus, where the abnormal accumulation of CSF can lead to increased intracranial pressure. The increasing incidence of such neurological disorders is driving continued innovation and adoption of CSF management solutions, ensuring better long-term outcomes for patients.

    Neurosurgery devices encompass a range of tools employed during surgical procedures aimed at treating brain and spinal cord conditions. As advancements in surgical techniques and technologies continue to evolve, neurosurgery devices are becoming more sophisticated, allowing for less invasive procedures that are crucial for patient safety and recovery. This segment significantly benefits from the integration of enhanced imaging systems and navigational tools, improving surgical accuracy and procedural success rates.

    Overall, the Product Type segment within the US Neurology Devices Market reflects a complex interplay of innovations spanning neurostimulation, interventional neurology, CSF management, and neurosurgery devices. Each niche segment is driven by distinct trends and technological advancements aimed at improving neurological health, thereby meeting the increasing demand for comprehensive treatment options within the clinical setting. The population's growing awareness of neurological disorders, combined with ongoing Research and Development, is expected to further propel market growth, making it a vital area of focus within the broader healthcare landscape.

    Source Primary Research, Secondary Research, MRFR Database and Analyst Review

    Neurology Devices Market End User Insights

    The rising prevalence of neurological diseases necessitates specialized services, leading to an increased demand for innovative devices. Trends such as technological advancements and the integration of telemedicine within these facilities are bolstering market growth. Additionally, the shift towards minimally invasive procedures and outpatient care is indicative of a fundamental transformation in the treatment paradigms, fostering greater efficiency and patient satisfaction. As neurology continues to evolve, these end users emerge as essential contributors to the US Neurology Devices Market, adapting to meet the complexities of neurological care in an ever-growing landscape.

    Get more detailed insights about US Neurology Devices Market

    Key Players and Competitive Insights

    The US Neurology Devices Market is characterized by a rapidly evolving landscape marked by advancements in technology, a focus on patient-centric solutions, and the increasing prevalence of neurological disorders. Competition within this market is fierce, driven by the need for innovative treatments and diagnostic tools that can improve patient outcomes. Companies are fostering collaborations with healthcare providers and engaging in strategic partnerships to enhance their market positions. Key factors influencing this competition include the regulatory environment, reimbursement policies, and ongoing research and development initiatives aimed at addressing unmet medical needs.

    Market stakeholders are also paying attention to shifting consumer preferences towards minimally invasive procedures and the integration of digital health technologies, which significantly impact product development and marketing strategies.

    Integra LifeSciences has established a significant presence within the US Neurology Devices Market, leveraging its extensive expertise in neurosurgery and neurocritical care. Known for its innovative neurocritical care solutions and surgical products, Integra LifeSciences has focused on developing high-quality devices that enhance surgical precision and safety. The company’s strength lies in its strong research and development pipeline, which enables it to introduce cutting-edge products that align with evolving clinical practices.

    Furthermore, the robust distribution network and committed customer service have solidified its position in the market, allowing Integra LifeSciences to respond effectively to the needs of healthcare professionals and institutions across the United States.

    TheraNest operates within the US Neurology Devices Market, offering a range of products and services aimed at improving clinical efficiency in mental health and neurological therapy settings. The company focuses on providing robust solutions that enhance data management and treatment accessibility for practitioners. TheraNest's key offerings include software solutions designed to streamline patient management and documentation, reflecting its commitment to supporting healthcare providers in delivering efficient care. The company has strengthened its market presence through strategic partnerships and acquisitions that allow it to expand its portfolio and enhance service delivery.

    TheraNest’s emphasis on user-friendly technology and integration capabilities has positioned it well amidst its competitors, making it a noteworthy entity in the realm of neurological devices tailored for the US market.

    Key Companies in the US Neurology Devices Market market include

    Industry Developments

    The US Neurology Devices Market has witnessed significant developments in recent months, with companies like Medtronic and Boston Scientific making strides in innovative treatments for neurological disorders. Integra LifeSciences announced the expansion of its neurosurgical product line to enhance patient outcomes in July 2023. Concurrently, Biogen's strategic initiatives have focused on the development of therapies for neurodegenerative diseases, showcasing their commitment to Research and Development.

    Additionally, in August 2023, Abbott Laboratories received FDA approval for a new neurostimulation device aimed at treating chronic pain. The market has experienced increased investments, particularly in NeuroSigma, which recently launched a groundbreaking device for managing epilepsy. In terms of mergers and acquisitions, there were no significant public mergers or acquisitions reported for these companies in the recent timeframe. Over the past two to three years, the market has shown continuous growth, driven by technological advancements and escalating incidences of neurological disorders, thereby raising the valuation of leading companies such as Stryker and Johnson and Johnson.

    This growth underscores the importance of innovation and collaboration in the evolving landscape of neurological healthcare in the United States.

    Market Segmentation

    Neurology Devices Market End User Outlook

    • hospitals & clinics
    • specialty center

    Neurology Devices Market Product Type Outlook

    • interventional neurology
    • csf management
    • neurosurgery devices

    Report Scope

    Report Attribute/Metric Details
    Market Size 2018 3.57(USD Billion)
    Market Size 2024 4.0(USD Billion)
    Market Size 2035 9.0(USD Billion)
    Compound Annual Growth Rate (CAGR) 7.651% (2025 - 2035)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2035
    Historical Data 2019 - 2024
    Market Forecast Units USD Billion
    Key Companies Profiled Integra LifeSciences, TheraNest, Zyga Technology, Medtronic, Boston Scientific, Abbott Laboratories, Stryker, Johnson  and  Johnson, Cochlear, NeuroSigma, Biogen, Blackrock Neurotech, NeuroPace, Neurovascular, Nervilab
    Segments Covered Product Type, End User
    Key Market Opportunities Telemedicine integration for patient care, Advanced neuroimaging technologies development, Wearable brain monitoring devices, Robotics in neurosurgery applications, Digital therapeutics for neurological disorders
    Key Market Dynamics Technological advancements, Aging population, Increasing prevalence of neurological disorders, Growing demand for minimally invasive procedures, Rising healthcare expenditure
    Countries Covered US

    FAQs

    What is the expected market size of the US Neurology Devices Market in 2024?

    The US Neurology Devices Market is expected to be valued at approximately 4.0 billion USD in 2024.

    What is the projected market size of the US Neurology Devices Market by 2035?

    By 2035, the US Neurology Devices Market is projected to grow to around 9.0 billion USD.

    What is the expected CAGR for the US Neurology Devices Market from 2025 to 2035?

    The expected CAGR for the US Neurology Devices Market from 2025 to 2035 is approximately 7.651%.

    Which product type is valued highest in the US Neurology Devices Market for 2024?

    In 2024, the neurostimulation segment is valued the highest at approximately 1.5 billion USD.

    What is the expected market value for interventional neurology devices in 2035?

    The interventional neurology segment is expected to value around 2.5 billion USD by 2035.

    Who are the key players in the US Neurology Devices Market?

    Key players in the US Neurology Devices Market include Medtronic, Boston Scientific, Abbott Laboratories, and Johnson & Johnson among others.

    What is the projected market value for neurosurgery devices in 2024?

    Neurosurgery devices are projected to have a market value of approximately 0.7 billion USD in 2024.

    How much is the CSF management segment expected to be valued by 2035?

    By 2035, the CSF management segment is anticipated to be valued at approximately 1.8 billion USD.

    What growth opportunities exist in the US Neurology Devices Market?

    The US Neurology Devices Market presents growth opportunities driven by advancements in technology and increased prevalence of neurological disorders.

    What impact will emerging trends have on the US Neurology Devices Market?

    Emerging trends, such as increased demand for minimally invasive procedures, are expected to positively influence the growth of the US Neurology Devices Market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials